KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Travere Therapeutics (TVTX) Goodwill: 2014-2025

Historic Goodwill for Travere Therapeutics (TVTX) over the last 11 years, with Sep 2025 value amounting to $800,000.

  • Travere Therapeutics' Goodwill changed negligibly% to $800,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $800,000, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $800,000 for FY2024, which is negligibly% changed negligibly from last year.
  • As of Q3 2025, Travere Therapeutics' Goodwill stood at $800,000, which was down 0.00% from $800,000 recorded in Q2 2025.
  • Travere Therapeutics' Goodwill's 5-year high stood at $936,000 during Q1 2021, with a 5-year trough of $800,000 in Q4 2022.
  • Moreover, its 3-year median value for Goodwill was $800,000 (2025), whereas its average is $818,182.
  • Data for Travere Therapeutics' Goodwill shows a maximum YoY dropped of 11.11% (in 2022) over the last 5 years.
  • Travere Therapeutics' Goodwill (Quarterly) stood at $900,000 in 2021, then decreased by 11.11% to $800,000 in 2022, then remained steady at $800,000 in 2023, then remained steady at $800,000 in 2024, then remained steady at $800,000 in 2025.
  • Its last three reported values are $800,000 in Q3 2025, $800,000 for Q2 2025, and $800,000 during Q1 2025.